Bayesian modelling of imperfect ascertainment methods in cancer studies
- 24 June 2005
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 24 (15) , 2365-2379
- https://doi.org/10.1002/sim.2116
Abstract
Tumour registry linkage, chart review and patient self‐report are all commonly used ascertainment methods in cancer epidemiology. These methods are used for estimating the incidence or prevalence of different cancer types in a population, and for investigating the effects of possible risk factors for cancer. Tumour registry linkage is often treated as a gold standard, but in fact none of these methods is error free, and failure to adjust for imperfect ascertainment can lead to biased estimates. This is true both if the goal of the study is to estimate the properties of each ascertainment type, or if it is to estimate cancer incidence or prevalence from one or more of these methods. Although rarely applied in the literature to date, when cancer is ascertained by three or more methods, standard latent class models can be used to estimate cancer incidence or prevalence while adjusting for the estimated imperfect sensitivities and specificities of each ascertainment method. These models, however, do not account for variations in these properties across different cancer sites. To address this problem, we extend latent class methodology to include a hierarchical component, which accommodates different ascertainment properties across cancer sites. We apply our model to a data set of 169 lupus patients with three ascertainment methods and eight cancer types. This allows us to estimate the properties of each ascertainment method without assuming any to be a gold standard, and to calculate a standardized incidence ratio for cancer for lupus patients compared to the general population. As our data set is small, we also illustrate the effects as more data become available. We show that our model produces parameter estimates that are substantially different from the currently most popular method of ascertainment, which uses tumour registry data alone. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 60 references indexed in Scilit:
- Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health ProfessionalsJNCI Journal of the National Cancer Institute, 2000
- Validity of self-reported Cancers in a Propsective Cohort Study in Comparison with Data from State Cancer RegistriesAmerican Journal of Epidemiology, 1998
- Comparison of the diagnosis of leukaemia from death certificates, cancer registration and histological reports - implications for occupational case-control studiesBritish Journal of Cancer, 1997
- Prevalence of cancer in the elderly: discrepancies between self-reported and registry dataBritish Journal of Cancer, 1997
- Latent class analysis in medical researchStatistical Methods in Medical Research, 1996
- Bayesian Estimation of Disease Prevalence and the Parameters of Diagnostic Tests in the Absence of a Gold StandardAmerican Journal of Epidemiology, 1995
- How accurate are Scottish cancer registration data?British Journal of Cancer, 1994
- Validation of Cancer Prevalence Data from a Postal Survey by Comparison with Cancer Registry RecordsAmerican Journal of Epidemiology, 1994
- Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma InvestigationBritish Journal of Cancer, 1993
- Estimation of test error rates, disease prevalence and relative risk from misclassified data: a reviewJournal of Clinical Epidemiology, 1988